About Us
Founded in 2019, River Med Pharm has quickly become a trusted name in the pharmaceutical industry. Our commitment to excellence is demonstrated by our adherence to the highest quality and safety standards, as evidenced by our Good Manufacturing Practices (GMP) certification.
Our mission
At River Med Pharm, our mission is to improve global health by producing high-quality, affordable pharmaceutical products. We strive for continuous innovation and adhere to strict standards to ensure the safety and effectiveness of our medications.
What we do
At River Med Pharm, our mission is to improve global health by producing high-quality, affordable pharmaceutical products. We are committed to continuous innovation and adherence to strict standards to ensure the safety and effectiveness of our medications. River Med Pharm began with an infusion line and has since expanded to include various other product lines. With our state-of-the-art manufacturing facilities, we specialize in producing a wide range of pharmaceutical products, including prescription medications, over-the-counter medications, and specialized medical therapies. Our advanced technology and skilled staff allow us to meet the diverse needs of healthcare providers and patients worldwide.
Quality assurance
Quality is at the heart of everything we do. Our GMP certification underscores our commitment to strict quality control measures at every stage of the production process. From raw material procurement to finished products, every step is meticulously monitored to ensure compliance with international standards.
700+
Employees
70+
Registered drugs
7
production lines
GMP, ISO
Certification
About Us
History of development
🟢 2019 — Company Founding
River Med Pharm was founded in 2019. A project to create a modern pharmaceutical production facility with a focus on sterile dosage forms began.
🟢 2022 — First GMP certificate
In 2022, the company received its first GMP certificate for its production line of infusion solutions in polymer vials, marking an important milestone in confirming quality and compliance with international requirements.
🟢 2023 — Launch of the enterprise
The official launch of the enterprise took place in 2023.
The opening ceremony was attended by President of Uzbekistan Shavkat Mirziyoyev, who emphasized the project's importance for the development of the country's pharmaceutical industry.
🟢 2025 — Expansion and new production lines
In 2025, the President of the Republic of Uzbekistan visited the enterprise.
As part of further development, new production areas were launched:
-
infusion solutions in polymeric vials;
-
infusion solutions in glass bottles;
-
dry powder antibiotics;
-
nasal sprays.
